< Back to companies

BrainFulness has developed a new technology for treating major depression, ADHD, and dementia. The company has built a working prototype of its technology and registered for patents in Israel, the United States, Germany, and Japan. The prototype was approved for human use by the Israeli Health Ministry, and BrainFulness has completed a clinical trial on chronic, treatment-resistant patients, yielding encouraging results without side effects.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2015
Website
brainfulnessltd.com/

Categories

TherapeuticsMental HealthNeurologyBehavioral Health Care

Disease Areas

Technologies

Therapeutic Devices
Only accessible to MedStartr community members. Join now

What do you think of BrainFulness?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now